Dave Nicoski ...
  • Ross LaDuke
EUR 246.10 For Business Accounts Only

Vermilion Compass: Weekly Equity Strategy

Market In “Wait-And-See” Phase

We started to see waning upside momentum in the S&P 500 last week with the rising wedge breakdown and 2760 support level violation on Tuesday. Despite this, there was no downside follow through the following day as investors digested a new $484B fiscal relief package. This led to the S&P 500 finding support at 2725-2735 which leads us to where we are now -- testing recent highs. We see waning upside momentum and several aspects continue to suggest the S&P 500 remains vulnerable to a pullback, but the market is simply not breaking down. We believe some near-term consolidation is the more likely scenario while the market is in a “wait-and-see” phase as it relates to states re-opening. As we highlight below, we are seeing some encouraging signs in the market but we are certainly not out of the woods.

· S&P 500 Short-Term Levels. Considering fluidity of the situation we map out support and resistance levels in the S&P 500 and adjust day by day as needed. The S&P 500 is testing the 2880-2900 resistance area. If there is a break above 2900, we see room up to 3000 or the 200-day MA area. Short-term support we are watching is at 2850, with bigger support below that at 2725-2735. A move below 2725-2735 is when the 2650 support level would come back into play... see chart below.

· Positive Developments Within Small-Caps, Equal-Weighted Discretionary. The small- vs. large-cap ratio (Russell 2000/S&P 500) is near 1.5-month highs and the Russell 2000 index is back above the 1270 resistance area we highlighted last week. Additionally, the equal-weighted Discretionary vs. Staples ratio exhibits a short-term bullish reversal. All of these are encouraging signs for the health of the broad market, but we need to see some follow through in order to believe there is staying power... see page 4.

· Negatives. The Dow Jones Transportation Average remains below resistance from the December 2018 lows. Major indexes in Europe and Asia remain below significant resistance, and not one of the major ex-US ETFs (EEM, ACWX, EFA) is above resistance. Additionally, the bond and commodity markets continue to disagree with the equity market, suggesting the S&P 500 is not out of the woods. As for the bond market, the 10-year yield remains pinned down and high yield spreads have widened over the past two weeks. When it comes to WTI and Brent crude oil prices, do not mistake the bottom of the page for support. We continue to see crude oil weakness as a bearish signal for the equity market... see pages 5-7.

ACM Research

ACM Research supplies capital equipment developed for the semiconductor industry. The company's tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory and 3D NAND-flash memory chips. The company also develops, manufactures and sells a range of packaging tools to wafer assembly and packaging customers. The company's technology and product include: Single Wafer Wet Cleaning Equipment for Front End Production Processes, which consist of its proprietary Space Alternated Phase Shift, Timely Energized Bubble Oscillation and Single-Wafer Tools for Back-End Assembly and Packaging, which provides a range of single-wafer tools for back-end wafer assembly and packaging factories.


ADTRAN is a provider of networking and communications equipment. The company's solutions and services enable voice, data, video and internet communications across a variety of network infrastructures. The company has two segments: Network Solutions, which provides solutions supporting fiber-, copper- and coaxial-based infrastructures and a number of wireless solutions, lowering the overall cost to deploy services across a range of applications for Carrier and Cable/multiple-service operator networks; and Services and Support, which provides turn-key suit of services to help operators accelerate deployment of their networks including planning, engineering, construction, installation, test, and turn-up.

Advanced Micro Devices Inc.

Advanced Micro Devices is a semiconductor company. The company primarily provides x86 microprocessors, as standalone devices or as incorporated into an accelerated processing unit, chipsets, graphics processing units (GPUs), data center and personnel GPUs, and development services; server and embedded processors, semi-custom System-on-Chip products, development services and technology for game consoles. The company also licenses portions of its intellectual property portfolio. The company's segments are: Computing and Graphics, which consists of desktop, notebooks, commercial, and chipsets products; and Enterprise, Embedded and Semi-Custom, which includes server processors, and embedded P\processors products.

Agnico Eagle Mines Limited

Agnico-Eagle Mines is a gold mining company with mining operations in Canada, Mexico and Finland. Co. earns a proportion of its revenues from the production and sale of gold in both dore bar and concentrate form. The remainder of revenue and cash flow is generated by the production and sale of byproduct metals. The revenue from byproduct metals is mainly generated by production at the LaRonde mine in Canada (silver, zinc, copper and lead) and the Pinos Altos mine in Mexico (silver).

Alamos Gold Inc.

Alamos Gold is engaged in the exploration, mine development, and the mining and extraction of precious metals, primarily gold. Co.'s s primary asset is the Mulatos Mine and holds the mineral rights to the Salamandra group of concessions in the State of Sonora, Mexico, which includes several known satellite gold occurrences.

Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals is a biopharmaceutical company serving patients and families affected by rare diseases through the discovery, development and commercialization of therapies. The company has developed and commercialized two complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, as well as the complement inhibitor to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis and neuromyelitis optica spectrum disorder in patients who are anti-aquaporin-4 antibody positive. In addition, the company has two enzyme replacement therapies for metabolic disorders, hypophosphatasia and lysosomal acid lipase deficiency.

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference (RNAi). RNAi is a biological pathway within cells for sequence-specific silencing and regulation of gene expression. The company has two RNAi-based medicines, ONPATTRO? (patisiran) and GIVLAARI? (givosiran). ONPATTRO is approved by the United States Food and Drug Administration (FDA) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and has also been approved in the European Union, Japan, Canada and Switzerland. GIVLAARI is approved by FDA for the treatment of adults with acute hepatic porphyria.

Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals is a pharmaceutical company focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient. The company has two reportable segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, naloxone, phytonadione, lidocaine, medroxyprogesterone acetate, Primatene? Mist, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin API and porcine insulin API.

Analog Devices Inc.

Analog Devices is an analog technology company. The company designs, manufactures, and markets a portfolio of solutions, including integrated circuits, algorithms, software, and subsystems. The company's analog products include data converter that translate real-world analog signals into digital data and also translate digital data into analog signals, amplifiers that condition analog signals, and power management and reference products that include functions such as power conversion, driver monitoring, sequencing and energy management. The company's digital signal processing products are designed to execute software programs, or algorithms, associated with processing digitized real-time, real-world data.

AngloGold Ashanti Ltd. ADS

Apellis Pharmaceuticals

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome. The most common available treatments for ADHD are stimulants that increase the brain chemicals dopamine and norepinephrine. Stimulants have significant side effects, and are classified as controlled substances which have significant potential for misuse, abuse and addiction. MDX is not a stimulant, and works with a different mechanism of action. MDX is a proprietary, combined rapid onset release formulation of the chemical Pyridoxine Pyroglutamate.

Bio-Rad Laboratories Inc. Class A

Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. The company has two primary segments: Life Science, which is engaged in the life sciences market and develops, manufactures and markets reagents, apparatus and laboratory instruments; and Clinical Diagnostics, which designs, manufactures, sells and supports test systems, informatics systems, test kits and quality controls that serve clinical laboratories in the diagnostics market. The company sells its products and services to a client base comprised of scientific research, healthcare, education and government customers.

Biohaven Pharmaceutical Holding Company Ltd.

Boston Beer Company Inc. Class A

Boston Beer Company is an alcoholic beverage company and a craft brewer. The company is engaged in the business of selling alcohol beverages throughout the United States and in selected international markets. The company's brands include Samuel Adams?, Twisted Tea?, Truly Hard Seltzer?, Wild Leaf? Hard Tea and Tura? Alcoholic Kombucha. The company produces alcohol beverages including malt beverages, hard cider and hard seltzer at the company-owned breweries and its cidery and under contract arrangements at other brewery locations. The company sells its products mainly in the United States, but also has markets in Canada, Europe, Israel, Australia, New Zealand, the Caribbean, the Pacific Rim, Mexico, and Central and South America.

Box Inc. Class A

Box provides a cloud content management platform that enables organizations to manage their content. With the company's Software-as-a-Service cloud content management platform, users can collaborate on content internally and with external parties, automate content-driven business processes, develop applications, and implement data protection, security and compliance features to comply with legal and regulatory requirements, internal policies and industry standards and regulations. The company's platform enables a set of business use cases across an enterprise and various file formats and media types. The company also provides offerings that address business needs via technology, services and marketing programs.

Bristol-Myers Squibb Company

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The company's products are sold worldwide, primarily to wholesalers, specialty distributors, retail pharmacies, hospitals, government entities and the medical profession. The company manufactures products in the United States and Puerto Rico and has manufacturing operations in two foreign countries. The company has products in the following therapeutic classes: hematology, oncology, cardiovascular and immunology. The company's pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics.

CACI International Inc Class A

CACI International is a holding company. Through its subsidiaries, the company is a provider of information solutions and services to the United States government. The company's information solutions and services support national security missions and government modernization/transformation for intelligence, defense, and federal civilian customers. The company provides its services and solutions to its domestic customers in the following market areas, among others: business systems, command and control, communications, cyber security, enterprise information technology (IT), health, and intelligence services. The company's international operations provide a mix of IT services and proprietary data and software products.

Catalent Inc

Catalent is a holding company. Through its subsidiaries, the company is a provider of delivery technologies and development solutions for drugs, biologics and consumer health products. The company operates in four segments: Softgel Technologies, which provides formulation, development and manufacturing services for soft capsules; Biologics and Specialty Drug Delivery, which provides drug substance development and manufacturing; Oral Drug Delivery, which provides various formulation development and manufacturing technologies; and Clinical Supply Services, which provides manufacturing, packaging, storage, distribution, project management, and inventory management for drugs and biologics in clinical trials.

ChromaDex Corp

ChromaDex is a provider of research and quality-control products and services to the natural products industry. Through its ingredients business segment, the company will continue to sell NIAGEN? in ingredient form to its strategic partners. In addition, the company will also continue to identify, acquire and commercialize other new proprietary ingredients and technologies. The company's products and services include: Consumer Products, which comprises TRU NIAGEN? branded dietary supplements; Ingredients, which includes Nicotinamide riboside NIAGEN? and Spirulina Extract Immulina?, a spirulina extract; and supplies a range of products necessary to conduct quality control of raw materials and consumer products.

Ciena Corporation

Ciena is a networking systems, services and software company, providing solutions that enable a range of network operators to deploy and manage networks that deliver services to businesses and consumers. The company provides hardware, software and services that support the transport, switching, aggregation, service delivery and management of video, data and voice traffic on communications networks. The company's solutions are used by communications service providers, cable and multiservice operators, Web-scale providers, submarine network operators, governments, enterprises, research and education institutions and other network operators.

CrowdStrike Holdings Inc. Class A

CrowdStrike is a holding company. Through its subsidiaries, the company provides a cloud-delivered solution for next-generation endpoint protection that offers 10 cloud modules on its Falcon platform via a SaaS subscription-based model that spans multiple large security markets, including endpoint security, security and IT operations (including vulnerability management), and threat intelligence. The company conducts its business in the United States, as well as locations internationally, including in Australia, Germany, India, Romania, and the United Kingdom.

Cue Biopharma Inc

Cue Biopharma is a biopharmaceutical company engaged in designing and developing a proprietary class of biologic product candidates engineered to selectively modulate the human immune system. The company's Immuno-STAT? (Selective Targeting and Alteration of T Cells) platform enables the company to engineer product candidates that it calls Immuno-STATs? or Immuno-STAT biologics? that directly engage with and direct the activity of antigen specific T cells in a patient's body through a singular molecular framework.


Danaher designs, manufactures and markets medical, industrial and commercial products and services. The company's segments include: Life Sciences, which provides research tools to study genes, proteins, metabolites and cells, in order to understand the causes of disease, identify therapies and test drugs and vaccines; Diagnostics, which provides analytical instruments, reagents, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions; and Environmental and Applied Solutions, which provides products and services to protect resources and global food and water supplies.

DocuSign Inc.

DocuSign provides e-signature solution as the main part of its cloud software suite for automating the agreement process. The company calls its suite the DocuSign Agreement Cloud. The DocuSign Agreement Cloud is designed to allow companies of various sizes and across various industries to make agreement, approval process, or transaction digital, from practically any device, from almost anywhere in the world.

Emergent BioSolutions Inc.

Emergent BioSolutions is a life sciences company. The company is focused on preparedness and response products and solutions that address the following categories: Chemical, Biological, Radiological, Nuclear and Explosives; emerging infectious diseases; travel health; emerging health crises; acute/emergency care; and contract development and manufacturing. The company also has a development pipeline consisting of a mix of both pre-clinical and clinical-stage product candidates, including Trobigard? a combination drug-device auto injector product candidate. In addition, the company has a fully integrated molecule-to-market biologics CDMO business offerings (development services, drug substance and drug product).

Etsy Inc.

Etsy provides sellers a marketplace with buyers along with a range of seller tools and services that are specifically designed to help its creative entrepreneurs generate more sales and scale their businesses. The company's platform includes the Etsy and Reverb Holdings, Inc. (Reverb) online marketplaces, its seller tools and services, its engaged sellers and buyers, and its technology. The company's primary marketplace,, is where buyers come to discover a selection of goods that are hard to find elsewhere. Reverb, the company's subsidiary, operates as a standalone marketplace. This two-sided marketplace connects buyers and sellers of new, used, and vintage musical gear from all over the world.

Exelixis Inc.

Exelixis is an oncology-focused biotechnology company that involved in the discovery, development and commercialization of new medicines for cancers. The company's marketd products are: CABOMETYX? (cabozantinib) tablets for renal cell carcinoma and previously treated hepatocellular carcinoma; and COMETRIQ? (cabozantinib) capsules for progressive, metastatic medullary thyroid cancer. The company's products resulting from its discovery efforts are: COTELLIC? (cobimetinib), an inhibitor of MEK approved as part of a combination regimen to treat melanoma; and MINNEBRO? (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan.

F5 Networks Inc.

F5 Networks is a provider of multi-cloud application services, which enable its customers to develop, deploy, operate, secure, and govern applications in any architecture, from on-premises to the public cloud. The company's application services are available as cloud-based, software-as-a-service, and software-only solutions supported for multi-cloud environments. In connection with its solutions, the company provides a range of services, including consulting, training, installation, maintenance, and other technical support services. The company's products and solutions include hardware platforms, software and software-as-a-service platforms, cloud-based managed services, and service provider solutions.

Fiverr International

Glu Mobile Inc.

Glu Mobile develops, publishes and markets a portfolio of mobile games designed to appeal to users who download and make purchases within the company's games through direct-to-consumer digital storefronts, such as the Apple App Store, Google Play store, and others. The company has a portfolio of games based on its own intellectual property as well as games based on third party licensed brands. The company sells virtual currency to consumers. In addition to in-app purchases of virtual currency, the company also monetizes its games through offers and in-game advertising. Offers enable users to acquire virtual currency without paying cash but by instead taking specified actions such as downloading another application.

Gold Fields Ltd. ADS

Haemonetics Corporation

Haemonetics is a healthcare company. The company has three product categories: Plasma, which includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers; Blood Center, which includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software; and Hospital, which is comprised of Hemostasis Management and Cell Processing products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, blood cell processing systems, disposables and blood transfusion management software.

Halozyme Therapeutics Inc.

Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. The company's approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. The company refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE? Drug Delivery Technology (ENHANZE). The company licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration.

Hologic Inc.

Hologic is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company's segments are: Diagnostics, which provides diagnostic products which are used to aid in the diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care for radiology, pathology and surgery; Medical Aesthetics, which provides aesthetic treatment systems, including SculpSure, PicoSure and MonaLisa Touch; GYN Surgical, which includes NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; and Skeletal Health, which includes the Horizon DXA, a dual energy x-ray system.

Immunomedics Inc.

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer. The company's product candidate is sacituzumab govitecan (IMMU-132), an antibody-drug conjugate for the treatment of patients with metastatic triple-negative breast cancer who previously received at least two prior therapies for metastatic disease. The company also has other product candidates, which target solid tumors and hematologic malignancies in various stages of clinical and preclinical development, such as labetuzumab govitecan that binds the CEACAM5 antigen expressed on CRC and other solid cancers, and IMMU-140 for the treatment of hematologic malignancies.

Incyte Corporation

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. JAKAFI (ruxolitinib) has been approved for the treatment of patients with intermediate or high-risk myelofibrosis, for the treatment of patients with polycythemia vera, and for the treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older. The company has also obtained a license to develop and commercialize ICLUSIG (ponatinib) in Europe and other select countries. In the European Union, ICLUSIG is approved for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia.

IRobot Corporation

iRobot is a consumer robot company. The company's portfolio of solutions features technologies for the connected home and concepts in cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company provides multiple Roomba floor vacuuming robots. The Braava robots automatically dust and damp mop hard-surface floors using cleaning cloths or the company's designed reusable microfiber cloths and include a reservoir that dispenses liquid throughout the cleaning cycle to keep the cloth damp. The robotic lawn mower, Terra t7 is being designed with a mapping and navigation system. Using the engaging Root Coding App, kids can learn coding fundamentals while they play, explore, and create.

Kraft Heinz Company

Kraft Heinz is a food and beverage company. The company manufactures and markets food and beverage products, including condiments and sauces, cheese and dairy, meals, meats, refreshment beverages, coffee, and other grocery products throughout the world. The company has three reportable segments defined by geographic region: United States, Canada, and Europe, Middle East, and Africa. The company's remaining businesses are combined and disclosed as Rest of World. Rest of World comprises two operating segments: Latin America and Asia Pacific.

Luminex Corp

Luminex develops, manufactures and sells biological testing technologies and products with applications in the life sciences industries, including diagnostics, pharmaceutical and research. The company delivers its products to various market segments, including multiplexing, reduction of labor and ability to test for proteins and nucleic acids. The company's products include: instruments, which include Luminex? 100/200?, FLEXMAP? 3D, MAGPIX?, ARIES?, and ARIES? M1; consumables, which include MicroPlex? Microspheres, MagPlex? Microspheres, and xTAG? Microspheres; software, which includes xPONENT?, TDAS?, SYNCT?, and IDEAS?; and clinical diagnostic assay product families, which include ARIES? Cassettes.

MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings is a holding company. Through its subsidiaries, the company is a provider of analog semiconductor solutions that enable internet applications, the cloud connected apps economy and the networked battlefield across the radio frequency (RF), microwave, millimeterwave and lightwave spectrum. The company's primary markets are: Telecom, which includes carrier infrastructure like long-haul/metro, 5G and fiber-to-the-X/passive optical network; Data Centers, enabled by a portfolio of analog ICs and photonic components for high speed optical module consumers; and Industrial and Defense, which includes military and commercial radar, RF jammers, electronic and countermeasures.

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company's main product candidate, MGL-3196 (resmetirom), is a proprietary, orally administered, small molecule, liver-directed, thyroid hormone receptor-? selective agonist being developed as a once-daily oral pill that can potentially be used to treat a number of disease states including non-alcoholic steatohepatitis.

Marvell Technology Group Ltd.

Marvell Technology Group is a semiconductor provider of application-specific products. The company is focused on the development of System-on-a-Chip devices, utilizing its technology portfolio of intellectual property in the areas of analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. The company develops integrated hardware platforms along with software that incorporates digital computing technologies. In storage, the company is engaged in fibre channel products and data storage controller solutions spanning cloud, enterprise, edge and personal computing markets. The company's networking products include ethernet solutions, embedded processors and WiFi connectivity solutions.

Mercury Systems Inc.

Mercury Systems is a commercial provider of sensor and safety processing subsystems. The company delivers solutions for a range of aerospace, commercial aviation, defense and intelligence programs. The company's products and solutions have been deployed in various programs with different defense prime contractors. The company's technologies and capabilities include embedded processing modules and subsystems, mission computers, rack-mount servers, avionics, radio frequency components, multi-function assemblies and subsystems. The company delivers subsystem level engineering capability and ongoing systems integration services to the subsystem market within the defense embedded electronics market segment.

Merit Medical Systems Inc.

Merit Medical Systems manufactures and markets proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. The company conducts its business through two segments: Cardiovascular, which includes its Peripheral Intervention, Cardiac Intervention, Cardiovascular and Critical Care, Interventional Oncology and Spine and Breast Cancer Localization and Guidance product groups; and Endoscopy, which provides non-vascular stents to treat gastrointestinal and pulmonary disease including AERO?, AEROmini? and AERO DV? Fully Covered Tracheobronchial Stents and Alimaxx-B? Biliary Stent Systems.

Monolithic Power Systems Inc.

Monolithic Power Systems is a fabless semiconductor company. The company designs, develops and markets power solutions for systems found in consumer, computing and storage, automotive, industrial, communications and consumer applications. The company's primary product families include the following: Direct Current (DC) to DC products, which are used to convert and control voltages within a range of electronic systems such as portable electronic devices, wireless Local Area Network access points, computers, and monitors, automobiles and medical equipment; and Lighting Control Products, which include lighting control integrated circuits that are used in backlighting and general illumination products.

Moody's Corporation

Moody's is a provider of credit ratings and assessment services; credit, capital markets and economic research, data and analytical tools; software solutions that support financial risk management activities; quantitatively derived credit scores; learning solutions and certification services; and company information and business intelligence products. The company's segments are: Moody's Investors Service, which publishes credit ratings on a range of debt obligations and the entities that issue such obligations in markets worldwide; and Moody's Analytics, which provides financial intelligence and analytical tools to assist businesses in making decisions.

National Beverage Corp.

National Beverage is a holding company. Through its subsidiaries, the company develops, produces, markets and sells a range of sparkling waters, juices, energy drinks and carbonated soft drinks. The company's brands consist of beverages for active and health-conscious consumer (Power+ Brands) including sparkling waters, energy drinks, and juices. The company's portfolio of Power+ Brands includes LaCroix?, LaCroix Curate?, LaCroix NiCola? and Shasta? Sparkling Water products; Rip It? energy drinks and shots; and Everfresh?, Everfresh Premier Varietals? and Mr. Pure? 100% juice and juice-based products. Additionally, the company produces and distributes carbonated soft drinks including Shasta? and Faygo? brands.


NeoPhotonics develops, manufactures and sells optoelectronic products that transmit, receive and switch high-speed digital optical signals for Cloud and data center internet content provider and telecom networks. The company focuses on products that operate at speed over distance, for 100 Gigabits per Second (G), 200G, and 400G and above data rates, such as at 600G and 800G. The company produces transmitter and receiver components and modules, as well as switching products, for 100G and beyond transmission over distances of two to 2,000 kilometers. The company integrates transmitter and receiver components into next generation pluggable transceiver modules.

Nordson Corporation

Nordson engineers, manufactures and markets differentiated products and systems used for dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces. The company serves a range of consumer non-durable, consumer durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, building and construction, and general product assembly and finishing. The company has three operating segments: Adhesive Dispensing Systems, Advanced Technology Systems, and Industrial Coating Systems.

OraSure Technologies Inc.

OraSure Technologies is engaged in two principal segments. The first is the company's OSUR business, which consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The second segment is the company's DNAG or molecular products and services business and is operated primarily through its subsidiaries. In the DNAG business, the company manufactures and sells kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing.

PayPal Holdings Inc

PayPal Holdings is a technology platform and digital payments company that enables digital and mobile payments on behalf of consumers and merchants worldwide. The company's combined payment solutions include its PayPal, PayPal Credit, Braintree, Venmo, Xoom and iZettle products and services. PayPal's payment solutions enable the company's customers to send and receive payments. PayPal helps merchants and consumers connect, transact, and complete payments, whether they are online, on a mobile device, in an app, or in person. The company provides proprietary payment solutions accepted by merchants that enable the completion of payments on the company's Payments Platform on behalf of its customers.


Personalis is a cancer genomics company transforming the development of therapies by providing molecular data about each patient's cancer and immune response. The company designed its NeXT Platform to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, in contrast to several cancer panels that cover roughly 50 to 500 genes.

Pfizer Inc.

Pfizer is a research-based biopharmaceutical company. The company is engaged in discovering, developing, manufacturing and distributing of healthcare products, including medicines and vaccines. The company manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Oncology, Inflammation and Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine business units, as well as a hospital business unit; Upjohn, which includes the company's solid oral dose brands such as Lyrica, Lipitor, Norvasc, Celebrex, Viagra, and certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business.

Pinterest Inc. Class A

Quanterix Corporation

Quanterix is a life sciences company that has developed digital immunoassay platforms. The company's platforms are based on its proprietary digital Simoa detection technology. The company's Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum and other fluids that, in a number of cases, are undetectable using analog immunoassay technologies, and also allow researchers to define and validate the function of protein biomarkers that are only present in low concentrations. The company is focusing on protein detection. In addition, the company is developing its Simoa bead-based technology to detect nucleic acids in biological samples.

Range Resources Corporation

Range Resources is a holding company. Through its subsidiaries, the company is an independent natural gas, natural gas liquids and oil company, engaged in the exploration, development and acquisition of natural gas and oil properties, located in the Appalachian and North Louisiana regions of the United States, primarily in the Marcellus Shale in Pennsylvania and the Lower Cotton Valley formation in Louisiana.

RealPage Inc.

RealPage is a provider of software and data analytics to the real estate industry. The company's platform consists of four categories of solutions: Property Management, which manages primary property management business processes, including leasing, accounting, budgeting, purchasing, facilities management, and support and advisory services; Leasing and Marketing, which manages primary leasing and marketing processes; Resident Services, which provides a platform to improve the transactional of prospects and renters and improve a property's reputation; and Asset Optimization, which provides analytics-based decision support for investment performance throughout the phases of real estate investment.

Redhill Biopharma

Repligen Corporation

Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. The company's bioprocessing business is comprised of: Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and OEM products, which are represented by its Protein A affinity ligands and cell culture growth factor products

Royal Gold Inc.

Royal Gold acquires and manages precious metal streams, royalties and similar interests. The company acquires existing stream and royalty interests or finances projects that are in production or in the development stage in exchange for stream or royalty interests. A metal stream is a purchase agreement that provides, in exchange for an upfront deposit payment, the right to purchase all or a portion of one or more metals produced from a mine, at a price determined for the life of the transaction by the purchase agreement. Royalties are non-operating interests in mining projects that provide the right to a portion of revenue or metals produced from the project after deducting specified costs, if any.

S&P Global Inc.

S&P Global is a provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide. The company's segments include: S&P Global Ratings, which provides credit ratings, research and analytics; S&P Global Market Intelligence, which provides multi-asset-class data, research and analytical capabilities that integrate cross-asset analytics and desktop services; S&P Global Platts, which provides information and benchmark prices for the commodity and energy markets; and S&P Dow Jones Indices, which provides a variety of valuation and index benchmarks for investment advisors, wealth managers and institutional investors.

Sapiens International Corp. N.V.

Sapiens International is a global provider of software solutions for the insurance industry. Co.'s offerings include a broad range of software solutions and services, comprised of (i) core software solutions for the insurance industry, including Property & Casualty/General Insurance (“P&C”) and Life, Annuities and Pensions (“L&P”) products, and record keeping software solutions for providers of Retirement Services (ii) variety of technology based solution including business decision management solutions for the financial services industry, including insurance, banking and capital markets and (iii) global services including project delivery and implementation of Co.'s software solutions.

Science Applications International Corp.

Science Applications International provides technical, engineering and enterprise information technology (IT) services. The company provides engineering, systems integration and information technology offerings for government projects and provides a range of services with an emphasis on differentiated technology services. The company's offerings include: engineering; technology and equipment platform integration; maintenance of ground and maritime systems; logistics; training and simulation; operation and program support services; and end-to-end services spanning the design, development, integration, deployment, management and operations, sustainment and security of its customers' entire IT infrastructure.

Scotts Miracle-Gro Company Class A

Scotts Miracle-Gro is a manufacturer and marketer of consumer lawn and garden products in North America. The company's segments are: United States Consumer, which consists of the company's consumer lawn and garden business located in United States; Hawthorne, which consists of the company's indoor, urban and hydroponic gardening business; and Other, which consists of the company's consumer lawn and garden business in geographies other than the United States and the company's product sales to nurseries, greenhouses and other customers. The company manufactures, markets and sells lawn and garden products in the following categories: lawn care, gardening and landscape, hydroponics, and controls.

Sequans Communications ADR

Silgan Holdings Inc.

Silgan Holdings is a holding company. Through its subsidiaries, the company manufactures rigid packaging for consumer goods products. The company operates three businesses; its metal container business, which used primarily by processors and packagers for food products, such as vegetables, soup, proteins, tomato based products, adult nutritional drinks and fruit ; its closures business, which manufactures metal and plastic closures and dispensing systems for food and beverage and health care products; and its plastic container business, which manufactures custom designed and stock plastic containers for personal care and health care products, including containers for mouthwash, shampoos, and conditioners. Inc. is a provider of Internet-based mailing and shipping solutions. The company's software solutions allow customers to print mailing and shipping labels for multiple carriers through downloadable software, web-based user interfaces and application programming interfaces. The company's solutions provide its customers with access to discounted carrier including the United States Postal Service and United Parcel Service. The company's customers primarily include small businesses, home offices, medium-size businesses, enterprises, e-commerce merchants, retailers and shippers including warehouses, fulfillment houses and omni-channel retailers. The company's operations consist of two segments and MetaPack.


Switch is a holding company. Through its subsidiaries, the company is engaged in technology infrastructure powering the sustainable growth of the connected world and the Internet of Everything. The company provides colocation space and related services to global enterprises, financial companies, government agencies, and others that conduct business on the internet. The company develops and operates data centers in Nevada, which are Tier IV Gold certified, and Michigan, and is developing data centers in Georgia, delivering redundant services with low latency and capacity transport environments.

Teradata Corporation

Teradata is a hybrid cloud analytics software provider. The company's solution, Teradata Vantage?, is its data warehouse and analytics platform that allows companies to utilize their data across an enterprise, whether on premises, in public or private clouds, or in a hybrid environment. The company's solutions are comprised of software, hardware, and related business consulting and support services. The company's business consulting services include a range of offerings, including consulting to help organizations establish an analytic vision, identify and operationalize analytical opportunities, enable an analytical ecosystem architecture, and ensure their analytical infrastructure delivers value.

Tradeweb Markets Inc. Class A

Tradeweb Markets is a leader in building and operating electronic marketplaces for its global network of clients across the financial ecosystem. The company's network is comprised of clients across the institutional, wholesale and retail client sectors, including many of the large global asset managers, hedge funds, insurance companies, central banks, banks and dealers, proprietary trading firms and retail brokerage and financial advisory firms, as well as regional dealers. The company's marketplaces facilitate trading across a range of asset classes, including rates, credit, money markets and equities. The company is a global company serving clients in 62 countries with offices in North America, Europe and Asia.

TreeHouse Foods Inc.

TreeHouse Foods is a consumer packaged food and beverage manufacturer operating across the United States, Canada, and Italy. The company's reportable segments are: Baked Goods, which sells bars, candy, cookies, crackers; in-store bakery products, pita chips, pretzels, refrigerated dough, and retail griddle waffles, pancakes, and French toast; Beverages, which sells broths, liquid non-dairy creamer, non-dairy powdered creamers, powdered drinks, ready-to-drink coffee, single serve hot beverages, teas, and sweeteners; and Meal Solutions, which sells aseptic cheese and pudding products, baking and mix powders, hot cereals, pasta, and skillet dinners, among others.

Turtle Beach Corp.

Turtle Beach is an audio technology company with capability in developing, commercializing and marketing products across a range of markets under the Turtle Beach? and ROCCAT? brands. The company designs and markets an assortment of audio peripherals for Xbox, PlayStation?, and Nintendo consoles, as well as for personal computers (PC), Mac?, and mobile/tablet devices. The company provides headset solutions for use across multiple platforms, including video game and entertainment consoles, handheld consoles, PC, tablets and mobile devices. ROCCAT is a gaming keyboards, mice and other accessories brand focused in the PC peripherals market.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. The company's product categories are: biologics, which include Crysvita? (burosumab) for the treatment of X-linked hypophosphatemia and Mepsevii? (vestronidase alfa) for the treatment of Mucopolysaccharidosis VII; small molecules, which includes UX007 for the treatment of long-chain fatty acid oxidation disorders; and gene therapy, which includes DTX301 for the treatment of patients with ornithine transcarbamylase deficiency and DTX401 for the treatment of patients with glycogen storage disease type Ia.

USANA Health Sciences Inc.

USANA Health Sciences develops and manufactures nutritional and personal care products. The company's principal product lines include: USANA? Nutritionals Essentials/CellSentials?, which inclides vitamin and mineral supplements that provide body nutrition for every age group beginning with children 13 months of age; Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs, such as cardiovascular health, skeletal/structural health, and digestive health; and Foods, which includes low-glycemic meal replacement shakes, snack bars, and other related products that provide macro-nutrition (carbohydrates, proteins, and fats) in various formats.


Zynex, through its subsidiary, Zynex Medical, Inc. (ZMI), designs, manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The ZMI devices are portable, battery operated and include an electrical pulse generator which is connected to the body via electrodes. ZMI also designs, manufactures and markets the NeuroMove product. The NeuroMove contains electromyography and electric stimulation technology that is primarily used for stroke, spinal cord and traumatic brain injury rehabilitation, by reaching parts of the brain to re-connect with muscles, also known as neuroplasticity.

Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch